Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 | ||
By: GlobeNewswire - 01 Feb 2024 | Back to overview list |
|
STAMFORD, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the fourth quarter of 2023 after the market closes on Tuesday, February 20, 2024. Management will host a conference call that day to discuss 2023 financial and operating results and share full year 2024 guidance at 4:30 p.m. Eastern Time. Conference Call Details About GeneDx Investor Relations Contact: Media Contact: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |